Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Moderna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.